TARIS Biomedical
Johnson & Johnson Innovative Medicine is dedicated to transforming cancer treatment through pioneering research, innovative therapies, and strategic collaborations. The company focuses on a wide range of oncology areas including bladder cancer, lung cancer, prostate cancer, multiple myeloma, and blood cancers, with a mission to eliminate cancer and improve patient outcomes. The company’s team of world-class experts in oncology is committed to scientific innovation, developing approaches to intercept cancer and move toward cures, guided by a strong ethical framework and a collaborative, diverse work environment.
Industries
Nr. of Employees
small (1-50)
TARIS Biomedical
Lexington, Massachusetts, United States, North America
Products
Digital patient support platform
Web-based platform offering personalized educational content, configurable behavioral coaching tools and a searchable resource connector to link patients to advocacy, clinical trial and local support services.
Digital patient support platform
Web-based platform offering personalized educational content, configurable behavioral coaching tools and a searchable resource connector to link patients to advocacy, clinical trial and local support services.
Services
Strategic partnerships and collaborative development
Engagement and co-development with external academic and industry partners, providing scientific, funding and commercialization expertise across the product lifecycle.
Molecular pathology and biomarker laboratory support
On-site laboratory capabilities for histochemistry, digital histology and molecular assays to support target validation, translational analyses and companion diagnostic development.
End-to-end clinical development and market access services
Cross-functional coordination of clinical development, medical affairs, strategic marketing and market access evidence generation to support product launch and adoption.
Preclinical and clinical evaluation of localized drug-delivery systems
Preclinical research and clinical programs to develop and evaluate localized delivery devices and protocols for sustained intravesical therapy and other local approaches.
Strategic partnerships and collaborative development
Engagement and co-development with external academic and industry partners, providing scientific, funding and commercialization expertise across the product lifecycle.
Molecular pathology and biomarker laboratory support
On-site laboratory capabilities for histochemistry, digital histology and molecular assays to support target validation, translational analyses and companion diagnostic development.
End-to-end clinical development and market access services
Cross-functional coordination of clinical development, medical affairs, strategic marketing and market access evidence generation to support product launch and adoption.
Preclinical and clinical evaluation of localized drug-delivery systems
Preclinical research and clinical programs to develop and evaluate localized delivery devices and protocols for sustained intravesical therapy and other local approaches.
Expertise Areas
- Clinical trial management with biomarker integration
- Biomarker discovery, validation and companion diagnostic development
- Intravesical and localized drug-delivery development and evaluation
- Immuno-oncology and tumor microenvironment research
Key Technologies
- Intravesical drug-delivery systems
- Molecular pathology and digital histology
- Biomarker assay development
- Bispecific and multispecific antibody platforms